| Literature DB >> 26028330 |
Wenzhe Si1, Wei Huang2, Yu Zheng2, Yang Yang2, Xujun Liu1, Lin Shan2, Xing Zhou2, Yue Wang2, Dongxue Su2, Jie Gao2, Ruorong Yan1, Xiao Han1, Wanjin Li1, Lin He1, Lei Shi2, Chenghao Xuan2, Jing Liang1, Luyang Sun1, Yan Wang3, Yongfeng Shang4.
Abstract
How loss-of-function of GATA3 contributes to the development of breast cancer is poorly understood. Here, we report that GATA3 nucleates a transcription repression program composed of G9A and MTA3-, but not MTA1- or MTA2-, constituted NuRD complex. Genome-wide analysis of the GATA3/G9A/NuRD(MTA3) targets identified a cohort of genes including ZEB2 that are critically involved in epithelial-to-mesenchymal transition and cell invasion. We demonstrate that the GATA3/G9A/NuRD(MTA3) complex inhibits the invasive potential of breast cancer cells in vitro and suppresses breast cancer metastasis in vivo. Strikingly, the expression of GATA3, G9A, and MTA3 is concurrently downregulated during breast cancer progression, leading to an elevated expression of ZEB2, which, in turn, represses the expression of G9A and MTA3 through the recruitment of G9A/NuRD(MTA1).Entities:
Mesh:
Substances:
Year: 2015 PMID: 26028330 DOI: 10.1016/j.ccell.2015.04.011
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743